Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Cerebrotendinous Xanthomatosis: Clinical Features of Affected Individuals From Latin America.

Martínez-Hernández HR, Villa-Villegas L, Piña-Avilés CE, Leal-Ortega R, Sáenz-Farret M, Camacho-Molina A, Zúñiga-Ramírez C.

Neurol Genet · 2026-10-09

DOI: 10.1212/nxg.0000000000200443PMID: 42924165

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis.

D'Souza L, Niharika BR, Benito-León J, Samarth BR, Das R, Kotwal M, Reddy K, Katti PA, Bhat CSP.

Tremor Other Hyperkinet Mov (N Y) · 2026-10-08

DOI: 10.5334/tohm.1278PMID: 42857721

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.

Corvol JC, Tesson C, Liot S, Carvalho S, Castelnovo G, Damier P, Defebvre L, Giordana C, Houeto JL, Marques A, Meissner WG, Remy P, Thobois S, Fabbri M, Rascol O, NS‐PARK cohort.

Mov Disord · 2026-10-08

DOI: 10.1002/mds.70537PMID: 42845097

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.

Scheperjans F, Borghammer P, Pfeiffer RF, Appel-Cresswell S, Keshavarzian A.

Mov Disord · 2026-10-08

DOI: 10.1002/mds.70566PMID: 42845110

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations.

Schneider RB, Skibinski G, Fiske B, Kopil CM, Merchant K, Simuni T.

J Parkinsons Dis · 2026-10-08

DOI: 10.1177/1877718x261493297PMID: 42847638

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.

Brakedal B, Skeie GO, Derad C, Alstadhaug KB, Anundskås I, Berven H, Biermann M, Bjørnarå KA, Torres Cleuren YN, Dalbro SEJ, Eidelberg D, Foldnes K, Fortes G, Haugarvoll K, Herlofson K, Hustad E, HogenEsch RI, Johanson GAS, Johnsen SH, Kunszt K, Kverneng S, Labusau A, Lie IH, Lilleng H, Lundervold K, Lundqvist C, Ma Y, McCann A, Njølstad TH, Pihlstrøm L, Riemer F, Rognerud AK, Sheard E, Simonsen AM, Storm E, Svensen M, Toker L, Tunold JA, Dölle C, Friede T, Tzoulis C.

JAMA · 2026-10-08

DOI: 10.1001/jama.2026.18828PMID: 42848371

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The Braak Paradox: When Parkinson Pathology and Clinical Progression Disconnect.

Rodríguez-Violante M.

Neurology · 2026-10-08

DOI: 10.1212/wnl.0000000000218535PMID: 42848965

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Relationship Between Braak and Clinical Stage in Autopsy-Confirmed Parkinson Disease: A UK Brain Bank Study.

di Biase L, Pecoraro PM, Bugamelli F, Di Carluccio M, Marsili L, Espay AJ.

Neurology · 2026-10-08

DOI: 10.1212/wnl.0000000000218469PMID: 42848968

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

Xiu W, Zhang G, Chen Y, Sun C, Gao Y, Li A, Zhang H, Shuai P, Cheng J, Wang J, Xiao X, Deng B.

Neurol Sci · 2026-10-07

DOI: 10.1007/s10072-026-09415-4PMID: 42839150

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.

Boßelmann CM, Vyhnalek M, Blichova Z, Novotna L, Meszarosova AU, Havránková P, Kuster E, Lauerer RJ, Hedrich UBS, Lyu H, Oosterloo M, Alber M, Schöls L, Müller-Schlüter K, Bischoff AT, Klopstock T, Koutsis G, Karadima G, Efthymiou S, Houlden H, Salazar-Villacorta A, Ellis CA, Scheper A, Gläser D, Haack TB, Wagner M, Zech M, Platzer K, Striano P, Syrbe S, Schüle R, Lerche H.

Mov Disord · 2026-10-07

DOI: 10.1002/mds.70555PMID: 42844944

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ahmed AAO, Ahmed OAO, Dishean AS, Gilbert C, Elkheir MMAS, Sota HA, Abdulaziz MAM, Mahmoud EYM, Ahmed RAO.

Parkinsons Dis · 2026-10-06

DOI: 10.1155/padi/9352886PMID: 42846716

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Rotigotine transdermal patch in Parkinson's disease: a narrative review of pharmacology, clinical evidence, special-population management, and health economics.

Sun X, Qian D, Zhao W, Zhang J, Hu X, Zhang Y.

Front Pharmacol · 2026-10-06

DOI: 10.3389/fphar.2026.1933610PMID: 42903465

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

7.691 makale bulundu

Cerebrotendinous Xanthomatosis: Clinical Features of Affected Individuals From Latin America.

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis.

Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.

The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations.

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.

The Braak Paradox: When Parkinson Pathology and Clinical Progression Disconnect.

Relationship Between Braak and Clinical Stage in Autopsy-Confirmed Parkinson Disease: A UK Brain Bank Study.

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Rotigotine transdermal patch in Parkinson's disease: a narrative review of pharmacology, clinical evidence, special-population management, and health economics.

Filtreler